Company / Tangible Book Value per Share
Terns Pharmaceuticals, Inc. Tangible Book Value per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$4.35
FY2024
5-year range
-$411.84 / $7.69
FY2020-FY2024
Trend
+21.4%
vs FY2023
Sector context
#103 of 207
Health Care
What the data says
At $4.35, Terns Pharmaceuticals, Inc.'s tangible book value per share ranks #103 of 207 in the Health Care sector. Declined from $7.69 to $4.35 over the past 2 years.
Based on SEC 10-K filings.
4.35 in FY2024 with a 3-year CAGR of -14.9%.
Declined from $7.69 to $4.35 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -14.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#103 of 207 in Health CareTop 50% of 207This company $4.35 Sector average $111.62
▼
-96.1% below sector average
Key checks
Key Insights
- In FY2024, tangible book value per share increased 21.4% year-over-year.
- Ranks #103 out of 207 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2022.
- Lowest tangible book value per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 7.86 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $4.35 | +21.4% |
| FY2023 | $3.58 | -53.4% |
| FY2022 | $7.69 | +8.9% |
| FY2021 | $7.06 | +101.7% |
| FY2020 | -$411.84 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026